{"doi":"10.2957/kanzo.29.289","title":"The natural history of HBV carriers. Seroconversion and seronegative of HBs.","abstract":null,"journal":"Kanzo","year":1988,"id":601780,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1543082,"name":"Toshihiko IUIMA","orcid":null,"position":1,"is_corresponding":false},{"id":1543083,"name":"Toshihiko NAMIHISA","orcid":null,"position":2,"is_corresponding":false},{"id":1543084,"name":"Koshi SAKUMA","orcid":null,"position":3,"is_corresponding":false},{"id":1543085,"name":"Akira TERANO","orcid":null,"position":4,"is_corresponding":false},{"id":1543081,"name":"Izumi YOSHINO","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"The natural history of HBV carriers. Seroconversion and seronegative of HBs.","abstract":"1973年より1985年の12年間に,男子HBs抗原キャリア1,196例の中から59例のHBs抗原消失例を見出した.12例にはHBs抗体が出現(HBs seroconversion)した.person-year法による年間HBs抗原消失率は0.99%であり,年間HBs seroconversion率は0.20%であった.年齢階層別の検討では,年間HBs抗原消失率は45歳以上で加齢と共に増加したが,年間HBs seroconversion率との関連は認められなかった.HBs抗原キャリア1,110例との比較から,HBs seroconversion例にはアルコールを全く飲まない例や,その経過中に肝機能の急性増悪を示した例が有意に多くみられた.以上の成績から,HBs抗原キャリアのHBs seroconversionは,HBs抗原の力価の漸減及び消失に引き続いておこるもののみではなく,その機序には様々な因子が関与するものと考えられた.","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21097893","pmcid":null,"openalex_id":"https://openalex.org/W2321832856","authors":[],"funders":[],"total_grants":0,"fwci":0.3218,"citation_percentile":0.63643041,"influential_citations":0,"citation_trend":[],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://www.jstage.jst.go.jp/article/kanzo1960/29/3/29_3_289/_pdf","host_type":"journal"},{"url":"https://www.jstage.jst.go.jp/article/kanzo1960/29/3/29_3_289/_pdf","host_type":"publisher"},{"url":"http://www.jstage.jst.go.jp/article/kanzo1960/29/3/29_3_289/_pdf","host_type":"publisher"},{"url":"https://doi.org/10.2957/kanzo.29.289","host_type":"journal"}],"fields_of_study":["Hepatitis B Virus Studies","Blood groups and transfusion","Hepatitis C virus research"],"mesh_terms":[],"keywords":["Seroconversion","Medicine","Virology","Natural history","Virus","Internal medicine"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T17:24:13.565943Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}